These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1891766)

  • 1. Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries.
    Araki H; Nishi K; Ishihara N; Okajima K
    Thromb Res; 1991 May; 62(3):209-16. PubMed ID: 1891766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity.
    Araki H; Muramoto J; Nishi K; Jougasaki M; Inoue M
    Circ Res; 1992 Sep; 71(3):577-84. PubMed ID: 1499106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effect of activated protein C and heparin on arterial thrombosis].
    Araki H
    Nihon Rinsho; 1992 Feb; 50(2):408-12. PubMed ID: 1613999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo.
    Araki H; Nishi K; Jougasaki M
    Circ Res; 1990 Aug; 67(2):312-8. PubMed ID: 2376073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antithrombotic effect of human activated protein C on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
    Yamashita T; Matsuoka A; Funatsu A; Yamamoto J
    Thromb Res; 1994 Jul; 75(1):33-40. PubMed ID: 8073406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged arterial occlusion caused by thrombus development at sites of arterial bifurcation.
    Araki H; Ishihara N
    Jpn Circ J; 1997 May; 61(5):413-20. PubMed ID: 9192241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis.
    Sakamoto T; Ogawa H; Yasue H; Oda Y; Kitajima S; Tsumoto K; Mizokami H
    Circulation; 1994 Jul; 90(1):427-32. PubMed ID: 8026029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vascular constriction on occlusive thrombus formation of rat mesenteric artery.
    Araki H; Nishi K
    Thromb Res; 1986 Oct; 44(1):39-45. PubMed ID: 3787560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses.
    Olsson E; Asko-Seljavaara S; Lassila R
    Thromb Haemost; 2002 Feb; 87(2):245-51. PubMed ID: 11858484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin.
    Tapparelli C; Metternich R; Gfeller P; Gafner B; Powling M
    Thromb Haemost; 1995 Apr; 73(4):641-7. PubMed ID: 7495072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
    Roux S; Tschopp T; Baumgartner HR
    J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit.
    Bevilacqua C; Finesso M; Prosdocimi M
    Thromb Res; 1991 May; 62(4):263-73. PubMed ID: 1866710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
    Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
    Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery.
    Mehta JL; Chen L; Nichols WW; Mattsson C; Gustafsson D; Saldeen TG
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):345-51. PubMed ID: 9514177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of laser arterial thrombus formation with unfractionated heparin.
    Doutremepuich F; Aguejouf O; Azougagh Oualane F; Doutremepuich C
    Haemostasis; 1993; 23(5):244-8. PubMed ID: 8175044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
    Weichert W; Pauliks V; Breddin HK
    Haemostasis; 1983; 13(1):61-71. PubMed ID: 6132858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis?
    Zhu Y; Tomasiak R; Fay WP
    Thromb Res; 2002 Mar; 105(5):413-8. PubMed ID: 12062543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.